Return to homepagePandemic Pact

Novel Cholera Conjugate Vaccine

Grant number: RF-BA-2024-V03

Grant search

Key facts

  • Disease

    Dengue

  • Start & end year

    2024
    2027

  • Known Financial Commitments (USD)

    $2,867,935.33

  • Funder

    RIGHT Foundation

  • Principal Investigator

    Julia Lynch

  • Research Location

    41, Belize

  • Lead Research Institution

    International Vaccine Institute (IVI)

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Phase 2 clinical trial

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Clinical Trial, Phase II

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Production of Clinical Trial Material and Conduct of a Phase 2 Trial of the Cholera Conjugate Vaccine